logo-loader
esense-Lab Ltd

eSense signs commercial distribution agreement to supply e-Juice

The company has finalised negotiations with California-based company VaporSpec.

E-liquid in use
E-liquids are used for vaporising and are a safer alternative to smoking

esense-Lab Ltd (ASX:ESE) has signed a commercial non-exclusive distribution agreement for the supply of e-Juice products to VaporSpec for distribution in the US and Canada.

The agreement calls for minimum quantities of e-Juice to be supplied in 10-millilitre bottles and will be renewed every three years.

Minimum annual quantities rise from 450,000 bottles in the first year to 5 million bottles in the third year of the agreement, with the numbers subject to a successful evaluation period with the purchase of at least 150,000 bottles during the first six months.

Additional testing programs

eSense CEO Haim Cohen said: “I am extremely pleased to announce to the market the distribution agreement eSense has signed with VaporSpec, a major player in the USA’s west coast vaping market.

“I am excited about this agreement and the various opportunities that the future holds for eSense.

“We are performing additional testing programs with companies in other markets as well, including the development of different products that will allow the company to grow in the food additive, food supplements, e-cigarette and other related markets.”

The agreement culminates a very long successful negotiation and expands the opportunities for use of the company’s terpenes in a variety of different sectors as well as demonstrating the penetration of the global e-liquid.

- Jessica Cummins

Quick facts: esense-Lab Ltd

Price: $0.02

Market: ASX
Market Cap: $4.55 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

1 day, 20 hours ago

2 min read